Horizon Pharma | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (41)

Latest Posts

About This Stock More About This Stock
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
Article By: Bio Deep Dives
Thursday, May 18, 2023 4:13 PM EDT
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
In this article: AMGN, HZNP Also: BMY
Read
5 Diverse Medical Stocks To Buy For 2023 And Beyond
Article By: Zacks Investment Research
Saturday, April 8, 2023 11:46 AM EDT
Healthcare will always be essential to society, making many health companies viable investments for growth. A look at the five top-rated stocks that investors may want to consider buying for 2023 and beyond.
In this article: HUM, NVO, CHGCY, HZNP, CSLLY
Read
Bausch Health Stock Soared By 20%: What To Do Now
Article By: Chris Lau
Monday, June 27, 2022 6:30 AM EDT
Market conditions are poor for Bausch. Investors have other biotechnology companies to consider instead, such as Horizon Therapeutics which has better growth prospects.
In this article: BHC, HZNP
Read
Insider Buying Detected – Buy This Biotech Now
Article By: Money Morning
Wednesday, February 23, 2022 6:21 AM EDT
Biotech and pharmaceutical research are the hottest growing sectors in the global business market, brought into the public eye by the onset of the COVID-19 pandemic.
In this article: ALPN, HZNP
Read
Paulson Adds Pretium, Exits United Tech In Q4
Article By: The Fly
Sunday, February 16, 2020 12:29 PM EDT
John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2019. The fund's top holdings as of December 31, in order of size, were Bausch Health, SPDR Gold Shares, Allergan, Discovery Class C and Horizon Therapeutics
In this article: AGN, CPE, PCG, QEP, S, TIF, UTX, LOGM, DISCK, GOLD, HZNP, TECD, GLD, PVG, CZR, BHC, NMRK, INSW, LYFT
Read

Latest Tweets for $HZNP

No tweets yet!

PARTNER HEADLINES